Leadership

Research Business & Operational Management

  • Scott Satin

    President and General Manager

    Mr. Satin manages the strategic and operational direction for BioTelemetry Research. He is an inventor of two of the company’s patented technologies for digital clinical data transfer and web-based, real-time data reporting. Mr. Satin has led the launch of all service lines and commercial expansion in the US and overseas. Mr. Satin obtained a master’s degree in Management and Systems from New York University and both master’s and bachelor’s degrees in Architecture from Tulane University.

  • Robert Goodman

    SVP, Sales & Marketing

    Mr. Goodman leads the company’s commercial team, expanding the client base and service lines across global regions and company sizes. Prior to joining the team he served as Director of Worldwide Sales and Marketing for Fisher BioServices, a Division of Thermo Fisher Scientific, where he directed the sales and marketing for the world’s leading provider of specialized biological material management services for pharmaceutical, biotech, and government agencies. Prior to joining Thermo Fisher he held numerous management roles at Pfizer. Previously, Mr. Goodman served in the US Army as a Captain, a Company Commander, and an Airborne Paratrooper. He obtained a Bachelor of Science degree from Norwich University.

  • Ron Way

    SVP, Organizational Strategies

    Ron Way serves as the SVP of Organizational Strategies for BioTelemetry Research. He provides oversight for project management and data management operations for both imaging and cardiac clinical trials. Prior to BioTelemetry Research, Mr. Way spent 25 years as the director of manufacturing operations for Ultralife Inc., a manufacturer of lithium battery systems for the military medical and consumer markets. Mr. Way was responsible for the integration of all of company manufacturing operations in Texas, Mississippi, and England, as well as the operational knowledge transfer to the company facility in China. Mr. Way has a B.S. degree in Business Management from the University of Phoenix. He received his Lean Six Sigma Black Belt Certification in 2009.

  • Zina Bulbuc

    Director, Regulatory Compliance

    Ms. Bulbuc manages the Regulatory and Quality System, ensuring the company’s compliance with all applicable regulations and guidelines. Prior to joining BioTelemetry Research, Ms. Bulbuc served in managerial and leadership positions with chemical, pharmaceutical, and dietary supplements FDA-regulated companies in Australia and the US. Ms. Bulbuc received her Master’s degree in Chemical Engineering — magna cum Laude — from “Gh. Asachi” Technical University in Romania, and her MBA with Honors from Mt. St. Mary’s University in Maryland, USA.

Research Scientific & Medical Management

  • Polina Voloshko, MD

    Chief Medical Officer

    Dr. Voloshko provides scientific and medical leadership, direction, training, and expertise to the BioTelemetry Research clinical trial staff, cardiologists, medical and scientific consultants, and sponsors. She has over 25 years of experience in clinical cardiology, ECG, ECHO, and Holter research. Prior to joining the company, she was VP of Cardiovascular Clinical Services at the Ischemia Research and Education Foundation and Gentiae Clinical Research. Previously, Dr. Voloshko served as a research fellow at the University of California San Francisco (UCSF) and Chief of Cardiology at Riga City Hospital in Riga, Latvia, an affiliate of the Latvian Medical University. Board-certified in cardiology and internal medicine, Dr. Voloshko received her MD, magna cum laude, at the First St. Petersburg Medical School in Russia.

  • Daniel Goodman, MD

    VP, Medical Director

    Dr. Goodman directs all aspects of protocol planning and development for sponsors, and for analysis of cardiac safety results. He is materially involved in innovations in medical technology and novel analyses, as well as in implementing the latest regulatory initiatives. He has direct interactions with key sponsor personnel and with academic experts to provide expert consulting solutions. Dr. Goodman received his training at Yale University and Cornell University Medical School. In the early 1990s, he founded Cardiology for Clinical Trials, one of the world’s first cardiac core labs. Dr. Goodman went on to be the medical director for Covance Cardiac Safety Services from 1994 until 2007. After this post, Dr. Goodman worked closely with the BioTelemetry Research medical team as a senior scientific consultant for several years until becoming the medical director in 2012. Dr. Goodman is an international thought leader in cardiac safety testing, developing protocols, producing scientific reports, conferring with regulators, and publishing extensively.

  • James Schuster, MD

    Medical Director & Senior Radiologist

    James Schuster, MD serves as a Medical Director and Senior Radiologist for BioTelemetry Research. In his role, he provides scientific and medical leadership, direction, training, and expertise to the BioTelemetry Research clinical trial staff, radiologists, technicians, medical and scientific consultants and sponsors. He brings over 20 years of experience in clinical radiology, along with medical and business leadership including Medical Director, Managing Partner, and CEO of a premier outpatient practice. Dr. Schuster received his BA in Biology from Cornell University and his MD from the University of Rochester (AOA Medical Honorary Society).

  • Jonathan Riek, PhD

    VP, Musculoskeletal & Metabolic Imaging

    Jonathan Riek, PhD serves as the Vice President of Musculoskeletal & Metabolic Imaging for BioTelemetry Research. He has a PhD in Electrical Engineering from the University of Rochester, and his doctoral thesis was on motion and artifact reduction in MRI. He worked on the development of a 3D CT scanner as a postdoctoral researcher, then spent 7 years in the research labs at the Eastman Kodak Company. While at Kodak, Jonathan worked in the areas of motion estimation, frame rate conversion, and video compression. He also served as the liaison between the image science division and the corporate software group. He joined VirtualScopics in 2000 to return to medical imaging and apply his skills interfacing between image science and software. In 2004, he led the development of the system that is still used to run clinical trials and analyze medical images. In his current role, Jonathan has scientific responsibility for all of Biotelemetry Research’s musculoskeletal and metabolic imaging studies, including arthritis, muscle diseases, diabetes, and liver diseases such as NASH and NAFLD. He holds four patents and has published many articles on various topics regarding MRI.

  • Edward Ashton, PhD

    VP, Oncology Imaging

    Edward Ashton serves as the Vice President of Oncology Imaging for BioTelemetry Research. In this role, he has provided technical leadership on more than 100 clinical trials in oncology and neurology over the past fifteen years. Dr. Ashton is a frequent speaker at international imaging conferences, and has authored many peer-reviewed publications describing his research. Prior to joining BioTelemetry Research, Dr. Ashton was a lead signal processing engineer at The MITRE Corporation in McLean, VA. Earlier in his career, he spent three years as a research engineer with the Naval Research Laboratory, where he received the Alan Berman Research Publication Award and was nominated for the Edison Award for Applied Science. Dr. Ashton has produced numerous articles on target detection and image analysis with military applications. He received both his PhD and MS degrees in electrical engineering from the University of Rochester, and his BS degree in electrical engineering from Loyola College.

  • Nelson Schiller, MD

    Senior Scientist

    Dr. Schiller is an international expert in the application and interpretation of echocardiography and is the founder of the UCSF Echocardiography Laboratory and the UCSF Adult Congenital Heart Disease Clinic. He has played an integral role in the development of many diagnostic and treatment techniques, including transesophageal echocardiography, Doppler pulmonary pressure determination, myocardial contrast perfusion, and echocardiography phase imaging for ventricular coordination. In the areas of congenital heart disease, he is an expert in the treatment of mitral and aortic valve diseases and hypertrophic cardiomyopathy. Dr. Schiller has more than 30 years of research experience in congenital heart disease, three-dimensional reconstruction, echocardiographic contrast agents, transesophageal echocardiography, coronary blood flow, exercise hemodynamics, myocardial perfusion, smoking-related cardiopulmonary disease, and non-invasive evaluation of cardiac synchrony. He received his MD from the SUNY School of Medicine in Buffalo, NY, before completing his residency at the University of California San Diego Hospital and his fellowship in cardiovascular diseases at the University of California San Francisco Medical Center.

Corporate Leadership